|
Introducing Health care associted infections affect several million patients world-wide each year. The impact to the patient as a result of infection is quite significant, ranging from discomfort to death, loss of time and money due to prolonged hospital stays and serious subsequent consequences that may result in future hospitalization and a shorter lifespan. The health care system also suffers as a result of health care associated infections, exposing health care workers to additional risk, consuming valuable resources, and incurring additional expenses, which are increasingly not reimbursed. Current best health care practices suggest the use of medical devices with an antimicrobial coating go a long way toward eliminating these deadly infections. The Centers for Disease Control and Prevention (CDC) estimates that there are approximately 99,000 deaths per year in the US attributed to health care associated infections.² In the US the cost of treating a health care associated infection is estimated between $20,000 and $25,000 per patient. Bacticent KB features the highly effective and patent-pending synergistic combination of chlorhexidine and protamine sulfate precisely dosed and delivered right from the surface of your medical device. Engineered to prevent the adhesion of biofilm and to outperform the commercially available silver and nitrofurazone coated devices against the most common bacteria associated with medical device-based infections. Bacteria Escherichia coli (E. coli) Enterococcus faecalis Biofilms Safely inside the biofilm’s protective polymeric matrix, the bacteria rapidly multiply and disperse, greatly increasing the risk to the patient, prolonging the hospital stay, and driving up the The Power of Two On Your Medical Device |
